ORAMED PHARMACEUTICALS INC. (ORMP) Stock Profile — Insider Trades & Financials

Revenue$0

Net Income$10.0M

EPS$1.26

Market Cap$142.8M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Nadav Kidron

CEO & Executive Director

Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.

Founded: 2002
Employees: 4
Headquarters: NEW YORK, NY, United States
Website: www.oramed.com

⚡

Core Efficiency

ROE?

5.01%

ROA?

4.34%

📊

Profitability Ratios

Current Ratio?

6.98

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Sep 11, 2026 (in 157 days)

Annual Report (10-K) — Based on filing pattern

Sep 11, 2026

Predicted10-K

Mar 26, 2026

10-KQ4 20250d after period end

Mar 26, 2026

10-KFY 202585d after period end

Nov 13, 2025

10-QQ3 20251d after period end

Aug 14, 2025

10-QQ2 20252d after period end

May 15, 2025

10-QQ1 20251d after period end

Jul 16, 2025

10-K/AQ4 2024111d after period end

Mar 27, 2025

10-KFY 202586d after period end

Nov 7, 2024

10-QQ3 20240d after period end

Loading company sections...

ORAMED PHARMACEUTICALS INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness